Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...

Point-of-care testing for common sexually transmitted infections may reduce overuse of antibiotics and improve emergency department workflow.

Genetic testing for hereditary cancers, such as breast, colon, pancreatic, and ovarian cancer, helps at-risk individuals understand their familial risk for these diseases and make informed decisions ...

Salvatore Viscomi MD, co-founder of Carna Health is an entrepreneur with a passion for digital health and remote patient monitoring. The Covid-19 pandemic taught us that providing care outside of ...

Point-of-care testing (POCT) includes professional-grade in vitro diagnostic tests completed in close proximity to patients. By performing diagnostic tests closer to patients and obtaining results ...

If proven to be accurate, the point-of-care test could provide the NHS with a highly scalable, low-cost diagnostic tool. It ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Please provide your email address to receive an email when new articles are posted on . Point-of-care saliva testing can detect HIV in 20 minutes. HIV testing rates jumped from 12% to 55% at a clinic ...

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...

Infectious diseases have been a major threat to human health throughout history, causing significant economic damage worldwide. In modern medicine, quickly and accurately identifying the germs causing ...

LONDON--(BUSINESS WIRE)--The global point-of-care coagulation testing market is poised to grow by USD 1 billion during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Request ...